Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neuronetics, Inc. - Common Stock
(NQ:
STIM
)
1.580
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuronetics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Which stocks are experiencing notable movement on Wednesday?
↗
February 11, 2026
Via
Chartmill
Top stock movements in today's session.
↗
February 11, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
February 11, 2026
Via
Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
February 11, 2026
Via
Chartmill
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Earnings Scheduled For August 5, 2025
↗
August 05, 2025
Via
Benzinga
Earnings Scheduled For May 6, 2025
↗
May 06, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
February 10, 2026
Via
Chartmill
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
↗
November 18, 2025
Via
Benzinga
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
November 12, 2025
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States
From
Neuronetics
Via
GlobeNewswire
Tuesday's pre-market session: top gainers and losers
↗
November 04, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss
↗
November 04, 2025
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.
Via
Chartmill
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
October 30, 2025
New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA Clinics
From
Neuronetics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 06, 2025
Via
Benzinga
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
September 17, 2025
Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) services
From
Neuronetics
Via
GlobeNewswire
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss
↗
August 05, 2025
Neuronetics (STIM) reported mixed Q2 2025 results, beating revenue estimates but posting a wider-than-expected loss, causing a 9% pre-market drop. Greenbrook clinics hit record revenue.
Via
Chartmill
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
July 30, 2025
Real-world data showing NeuroStar is effective in adolescents and young adults with depression from the world’s largest TMS outcomes dataset
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
June 10, 2025
NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company’s ongoing commitment to clinical innovation and excellence
From
Neuronetics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 27, 2025
Via
Benzinga
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
May 14, 2025
From
Neuronetics
Via
GlobeNewswire
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
March 31, 2025
Policy update increases access for millions covered by Evernorth Health Services
From
Neuronetics
Via
GlobeNewswire
What's going on in today's pre-market session
↗
February 07, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 07, 2025
Via
Benzinga
Earnings Scheduled For March 4, 2025
↗
March 04, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
February 06, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression
January 29, 2025
Advancing mental health treatment through innovative research, offering insights on symptom improvement and clinical tools
From
Neuronetics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 12, 2024
Via
Benzinga
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
October 14, 2024
Data selected for oral presentation reinforce previous findings on safety and efficacy
From
Neuronetics
Via
GlobeNewswire
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
September 25, 2024
Policy update increases access for millions covered by HCSC BlueCross BlueShield policies
From
Neuronetics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
